The impact of early neuraminidase inhibitor therapy on clinical outcomes in patients hospitalised with influenza A-related pneumonia: a multicenter, retrospective study

BACKGROUND: Guidelines emphasize prompt antiviral treatment in severe influenza patients. Although nearly a 50% of severe influenza present with pneumonia, the effect of early (≤ 2 days after illness onset) neuraminidase inhibitor (NAI) use on the clinical outcomes of influenza A-related pneumonia (...

Full description

Saved in:
Bibliographic Details
Published in:BMC Infect Dis
Main Authors: Chen, Liang, Han, Xiudi, Li, Yan Li, Zhang, Chunxiao, Xing, Xiqian
Format: Artigo
Language:Inglês
Published: BioMed Central 2020
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7447583/
https://ncbi.nlm.nih.gov/pubmed/32842994
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-020-05322-x
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items